| Dr Kenneth J Koerner, DC | |
|
1504 Vine St, Ste. B, Hays, KS 67601-3455 | |
| (785) 628-2105 | |
| (785) 628-2165 |
| Full Name | Dr Kenneth J Koerner |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 16 Years |
| Location | 1504 Vine St, Hays, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558501254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 01-05244 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Koerner Chiropractic Pa | 8921137993 | 4 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.
Communicating effectively during an outbreak can be tricky for government agencies charged with protecting the public, according to Glen Nowak, former director of media relations at the Centers for Disease Control and Prevention and professor of advertising and public relations at the University of Georgia's Grady College of Journalism and Mass Communication.
Disruptive behaviors in childhood are among the most prevalent and costly mental health problems in industrialized countries and are associated with significant negative long-term outcomes for individuals and society.
› Verified 9 days ago
| Provider Name | Koerner Chiropractic Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215269253 PECOS PAC ID: 8921137993 Enrollment ID: O20100601000330 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.
Communicating effectively during an outbreak can be tricky for government agencies charged with protecting the public, according to Glen Nowak, former director of media relations at the Centers for Disease Control and Prevention and professor of advertising and public relations at the University of Georgia's Grady College of Journalism and Mass Communication.
Disruptive behaviors in childhood are among the most prevalent and costly mental health problems in industrialized countries and are associated with significant negative long-term outcomes for individuals and society.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth J Koerner, DC 1504 Vine St, Ste. B, Hays, KS 67601-3455 Ph: (785) 628-2105 | Dr Kenneth J Koerner, DC 1504 Vine St, Ste. B, Hays, KS 67601-3455 Ph: (785) 628-2105 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.
Communicating effectively during an outbreak can be tricky for government agencies charged with protecting the public, according to Glen Nowak, former director of media relations at the Centers for Disease Control and Prevention and professor of advertising and public relations at the University of Georgia's Grady College of Journalism and Mass Communication.
Disruptive behaviors in childhood are among the most prevalent and costly mental health problems in industrialized countries and are associated with significant negative long-term outcomes for individuals and society.
› Verified 9 days ago
Dr. Jakob Haworth, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2522 Vine St, Unit 1, Hays, KS 67601 Phone: 785-432-1147 | |
Vinton K Arnett, D.C.,P.A. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2705 Vine St, Ste 5, Hays, KS 67601 Phone: 785-628-3622 Fax: 785-628-3922 | |
Dr. Andrea Michelle Stephens, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1007 Cody Ave Ste A, Hays, KS 67601 Phone: 785-621-0621 | |
Koerner Chiropractic & Physical Therapy Chiropractor Medicare: Medicare Enrolled Practice Location: 2707 Vine St, Suite 1, Hays, KS 67601 Phone: 785-628-2105 Fax: 785-628-2165 | |
Lane Kyle Carpenter, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2522 Vine St Unit 1, Hays, KS 67601 Phone: 785-432-1147 | |
Dr. Robin Hale, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2705 Vine St, Ste 5, Hays, KS 67601 Phone: 785-628-3622 Fax: 785-628-3922 | |
Dr. Paul J. Solomon, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1301 Pine St, Ste A, Hays, KS 67601 Phone: 785-625-6115 |